The role of antiviral programs in bacterial sepsis

NIH RePORTER · NIH · R01 · $401,016 · view on reporter.nih.gov ↗

Abstract

Project Summary/Abstract Sepsis is the most common cause of acute kidney injury in the intensive care unit and is coupled with very high mortality. It is a highly dynamic pathological state in which a wide array of pro- and anti-inflammatory pathways are aberrantly activated, resulting in a complex syndrome that evolves rapidly over hours. Therefore, determining the timeline of sepsis and developing timeline-specific therapies are essential for successful interventions. Recently, we examined temporal changes in the translatome of the kidney in animal models of bacterial sepsis. We showed that 1) initial outburst of inflammation is accompanied by significant increases in RNA transcription and translation, 2) the initial inflammatory phase is followed by activation of antiviral programs, and 3) the activation of antiviral programs leads to translation shutdown—a hallmark of late phase sepsis. Crucially missing from this recent work is the nature and source of the antiviral program activators in the absence of an actual viral infection. We hypothesize that induction of the initial inflammatory cascades results in a state of self-RNA overburden, which provokes a milieu resembling that of a viral infection. In this proposal, we will investigate the role of endogenous RNA stress as the determinant of antiviral program activation and resultant sepsis-induced organ failure. This work will provide an important framework for understanding the link between the early phase inflammation and late phase total organ shutdown, and could lead to novel diagnostic and therapeutic applications in sepsis-induced kidney failure.

Key facts

NIH application ID
10459508
Project number
5R01AI148282-03
Recipient
INDIANA UNIVERSITY INDIANAPOLIS
Principal Investigator
Takashi Hato
Activity code
R01
Funding institute
NIH
Fiscal year
2022
Award amount
$401,016
Award type
5
Project period
2020-09-23 → 2025-08-31